Fluoroquinolone antibiotics: in vitro antibacterial and time-kill bactericidal evaluation against etiology of bacteremia in human immunodeficiency virus (HIV)-infected patients

Bulletin of the National Research Centre

Table 3 Minimum inhibitory and minimum bacteriocidal concentrations of fluoroquinolone antibiotics against etiology of bacteremia in HIV-infected patients

Bacterial isolates	Isolate codes	MIC (µg/mL)			MBC (µg/mL)			MBC/MIC ratios
Bacterial isolates	Isolate codes	OFL	LEV	CIP	OFL	LEV	CIP	OFL	LEV	CIP
P. aeruginosa	PA09	6.25	12.5	6.25	12.5	25	12.5	2	2	2
H. influenzae	HI27	25	12.5	12.5	50	12.5	25	2	1	2
Acinetobacter spp	AS01	50	25	50	50	50	50	1	2	1
K. pneumoniae	KP32	12.5	12.5	25	25	25	50	2	2	2
K. pneumoniae	KP26	12.5	12.5	12.5	25	12.5	12.5	2	1	1
S. typhi	ST07	50	25	50	50	25	50	1	1	1
S. typhi	ST40	> 50	25	50	> 50	50	50	1	2	1
E. aerogenes	EA01	12.5	12.5	12.5	12.5	12.5	25	1	1	2
S. aureus	SA08	25	12.5	12.5	25	25	25	1	2	2
S. aureus	SA21	50	25	50	50	50	50	1	2	1
S. pneumoniae	SP02	12.5	25	12.5	25	50	25	2	2	2
S. pneumoniae	SP10	50	25	12.5	50	50	25	1	2	2

MIC Minimum inhibitory concentration, MBC minimum bacteriocidal concentration, OFL Ofloxacin, LEV Levofloxacin, CIP Ciprofloxacin